Oxford Biomedica plc (OXBDF)
OTCMKTS · Delayed Price · Currency is USD
11.34
+0.09 (0.78%)
At close: Feb 11, 2026
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of $1.35 billion as of February 12, 2026. Its market cap has increased by 146.68% in one year.
Market Cap
1.35B
Enterprise Value
1.42B
Revenue
207.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
$11.34
Market Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 27.87M to 1.35B, an increase of 4,726.47%. That is a compound annual growth rate of 14.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.35B | 34.40% |
| Dec 31, 2025 | 1.00B | 79.70% |
| Dec 31, 2024 | 557.04M | 105.34% |
| Dec 29, 2023 | 271.27M | -47.15% |
| Dec 30, 2022 | 513.24M | -64.22% |
| Dec 31, 2021 | 1.43B | 23.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |